Windtree Therapeutics Inc (WINT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.2100 +0.0400 (+3.42%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.2200 +0.0100 (+0.83%) 19:58 ET
for Fri, Apr 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -1,787 | -20,291 | -39,208 | -67,636 | -32,566 |
Depreciation Amortization | 181 | 3,140 | 19,977 | 45,212 | 168 |
Income taxes - deferred | -210 | N/A | -1,367 | -9,987 | N/A |
Accounts payable and accrued liabilities | 1,070 | 560 | -444 | -468 | -547 |
Other Working Capital | 1,371 | 2,018 | -1,777 | -58 | -1,328 |
Other Operating Activity | -16,027 | 1,136 | 3,367 | 9,273 | 8,958 |
Operating Cash Flow | $-15,402 | $-13,437 | $-19,452 | $-23,664 | $-25,315 |
Cash Flows From Investing Activities | |||||
PPE Investments | -12 | -15 | 197 | -279 | -291 |
Investing Cash Flow | $-12 | $-15 | $197 | $-279 | $-291 |
Cash Flows From Financing Activities | |||||
Debt Issued | 1,862 | N/A | N/A | 1,000 | 3,347 |
Debt Repayment | -605 | -797 | -1,174 | -3,872 | -3,776 |
Common Stock Issued | 4,120 | 11,637 | N/A | 27,390 | 20,387 |
Dividend Paid | -657 | N/A | N/A | N/A | N/A |
Other Financing Activity | 8,013 | 755 | 4,253 | 4,843 | 0 |
Financing Cash Flow | $12,733 | $11,595 | $3,079 | $29,361 | $19,958 |
Beginning Cash Position | 4,469 | 6,326 | 22,502 | 17,084 | 22,732 |
End Cash Position | 1,788 | 4,469 | 6,326 | 22,502 | 17,084 |
Net Cash Flow | $-2,681 | $-1,857 | $-16,176 | $5,418 | $-5,648 |
Free Cash Flow | |||||
Operating Cash Flow | -15,402 | -13,437 | -19,452 | -23,664 | -25,315 |
Capital Expenditure | -12 | -15 | -13 | -279 | -291 |
Free Cash Flow | -15,414 | -13,452 | -19,465 | -23,943 | -25,606 |